Showing results (71-80 of 211) with videos related to
Sort By:
Pageof 22
Gastroenterology|January 10, 2002
Fractalkine-mediated signals regulate cell-survival and immune-modulatory responses in intestinal epithelial cellsStephan Brand, Takanori Sakaguchi, Xiubin Gu, et al.American Journal of Physiology. Cell Physiology|March 31, 2006
Transcriptional repression of Na-K-2Cl cotransporter NKCC1 by hypoxia-inducible factor-1Juan C Ibla, Joseph Khoury, Tianqing Kong, et al.Tissue Barriers|April 4, 2015
Metabolic regulation of intestinal epithelial barrier during inflammationSean P Colgan, Valerie F Curtis, Jordi M Lanis, et al.The Journal of Biological Chemistry|March 20, 2009
Adenosine signaling mediates SUMO-1 modification of IkappaBalpha during hypoxia and reoxygenationQian Liu, Jing Li, Joseph Khoury, et al.Journal of Molecular Medicine (Berlin, Germany)|May 22, 2017
Tissue metabolism and the inflammatory bowel diseasesJordi M Lanis, Daniel J Kao, Erica E Alexeev, et al.American Journal of Physiology. Cell Physiology|August 1, 2022
Hypoxia-inducible factor as a bridge between healthy barrier function, wound healing, and fibrosisCalen A Steiner, Ian M Cartwright, Cormac T Taylor, et al.Gut Microbes|February 15, 2021
Intestinal Inflammation as a Dysbiosis of Energy Procurement: New Insights into an Old TopicJ Scott Lee, Ruth X Wang, Erica E Alexeev, et al.Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research|April 7, 2005
Cholera toxin potentiates influences of IFN-gamma through activation of NF-kappaB and release of tumor necrosis factor-alphaRichard S Blumberg, Richard S Pitman, Cormac T Taylor, et al.Proceedings of the National Academy of Sciences of the United States of America|May 14, 2020
Microbiota-derived butyrate dynamically regulates intestinal homeostasis through regulation of actin-associated protein synaptopodinRuth X Wang, J Scott Lee, Eric L Campbell, et al.Nutrients|April 30, 2021
Creatine Supplementation for Patients with Inflammatory Bowel Diseases: A Scientific Rationale for a Clinical TrialTheo Wallimann, Caroline H T Hall, Sean P Colgan, et al.Pageof 22